BMRN logo

BMRN
Biomarin Pharmaceutical Inc. - Registered Shares

5,340
Mkt Cap
$10.54B
Volume
2.53M
52W High
$69.87
52W Low
$50.76
PE Ratio
31.70
BMRN Fundamentals
Price
$56.49
Prev Close
$54.79
Open
$54.91
50D MA
$58.38
Beta
0.69
Avg. Volume
2.43M
EPS (Annual)
$1.80
P/B
1.78
Rev/Employee
$1.01M
$10,813.39
Loading...
Loading...
News
all
press releases
BioMarin Pharmaceutical (NASDAQ:BMRN) Rating Increased to Strong-Buy at Truist Financial
Truist Financial raised BioMarin Pharmaceutical to a "strong-buy" rating in a research report on Wednesday...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
BioMarin (BMRN) Down 13.6% Since Last Earnings Report: Can It Rebound?
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·7d ago
News Placeholder
Swiss Life Asset Management Ltd Sells 54,282 Shares of BioMarin Pharmaceutical Inc. $BMRN
Swiss Life Asset Management Ltd decreased its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 72.8% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,285 shares of the biotechnology company's stock after selling...
MarketBeat·8d ago
News Placeholder
BioMarin Pharmaceutical (NASDAQ:BMRN) Shares Gap Down - Time to Sell?
BioMarin Pharmaceutical (NASDAQ:BMRN) Shares Gap Down - What's Next...
MarketBeat·16d ago
News Placeholder
Boone Capital Management LLC Sells 118,903 Shares of BioMarin Pharmaceutical Inc. $BMRN
Boone Capital Management LLC lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 26.6% during the 3rd quarter, according to the company in its most recent Form...
MarketBeat·17d ago
News Placeholder
Braidwell LP Acquires Shares of 528,000 BioMarin Pharmaceutical Inc. $BMRN
Braidwell LP acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange...
MarketBeat·17d ago
News Placeholder
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twenty-four ratings firms that are presently covering the...
MarketBeat·17d ago
News Placeholder
BioMarin Pharmaceutical (NASDAQ:BMRN) EVP Sells $996,743.56 in Stock
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) EVP Charles Greg Guyer sold 16,486 shares of the firm's stock in a transaction dated Wednesday, March 11th. The shares were sold at an...
MarketBeat·19d ago
News Placeholder
EVP Of BioMarin Pharmaceutical Sold $996K In Stock
read more...
Benzinga·19d ago
News Placeholder
BioMarin Pharmaceutical Highlights Growth Plan, VOXZOGO Milestones, and Amicus Deal at Conference
BioMarin Pharmaceutical (NASDAQ:BMRN) executives highlighted a three-pillar strategy focused on growth, innovation, and value commitment during a fireside chat hosted by Leerink Partners' Joe...
MarketBeat·19d ago
<
1
2
...
>

Latest BMRN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.